hrmy: the income statement

MyFinsight

Harmony Biosciences Holdings, Inc. (HRMY)

For the quarter ending 2025-06-30, HRMY made $200,489K in revenue. $39,770K in net income. Net profit margin of 19.84%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30	2025-03-31	2024-09-30	2024-06-30
Net product revenue	200,489	184,733	186,038	172,814
Cost of product sold	38,153	31,994	42,778	32,144
Gross profit	162,336	152,739	143,260	140,670
Sales and marketing	30,073	30,711	27,576	28,507
Research and development	50,159	34,540	25,387	63,583
General and administrative	33,924	31,243	28,587	27,224
Total operating expenses	114,156	96,494	81,550	119,314
Operating income	48,180	56,245	61,710	21,356
Interest income	5,296	5,044	4,932	4,705
Interest expense	3,646	3,836	4,348	4,404
Other expense, net	-193	-276	-124	37
Income before income taxes	49,637	57,177	62,170	21,694
Income tax expense	9,861	11,617	16,077	10,103
Net income	39,776	45,560	46,093	11,591
Unrealized income (loss) on investments	-6	179	733	-63
Comprehensive income	39,770	45,739	46,826	11,528

Earnings per share, basic	0.69	0.79	0.81	0.2
Earnings per share, diluted	0.68	0.78	0.79	0.2
Weighted average number of shares outstanding, basic	57,469,775	57,309,938	56,870,234	56,802,357
Weighted average number of shares outstanding, diluted	58,427,134	58,524,566	58,103,963	57,541,696

Unit: Thousand (K) dollars (except for numbers of shares and EPS)